In the present study, we performed a two‐stage survival analysis to specifically estimate the association between overall survival in PC patients and genetic variants of the 16 genes belonging to the PKN1/FAK/PI3K/AKT pathway. This evidence concerns the gene PKN1 and pachyonychia congenita.